Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Public discussions about personal health are currently experiencing a very positive shift. Today, numerous prominent figures openly share their successful medical journeys. These honest accounts actively reduce the longstanding social stigma surrounding obesity. People now view metabolic conditions through a…
GLP-1 drugs aren’t just for diabetes anymore. These medications now treat weight loss and obstructive sleep apnea too, and researchers keep finding new uses for them. Here’s how they work. GLP-1 drugs copy a natural hormone called glucagon-like peptide-1. That…
The landscape of weight management and obesity care is undergoing a remarkable transformation. For decades, patients and healthcare providers struggled to find safe, effective, and long-lasting medical options for weight loss. Today, the conversation has completely shifted. The arrival of…
Burger King is already thinking ahead. The company wants to prepare for a future where weight loss drugs change how Americans eat. Tom Curtis runs the chain’s U.S. and Canada business. He laid out the strategy in a recent interview…
Millions of older Americans just got a new option for tackling obesity. It comes with a price tag most people can actually afford. Starting July 1, 2026, Medicare will cover certain GLP-1 weight loss drugs through a new program called…
GLP-1 drugs like Ozempic and Wegovy have changed things for a lot of people. For those dealing with obesity or type 2 diabetes, these medications have delivered results that felt impossible before. They work, and the science behind them is…
A new forecast from pharmaceutical intelligence firm Evaluate suggests Eli Lilly’s tirzepatide franchise is on track to make commercial history. The company’s World Preview report projects that Mounjaro and Zepbound could together generate more than $70 billion in annual sales…
Glucagon-like peptide-1 (GLP-1) medications have completely transformed modern healthcare in recent years. Originally, doctors prescribed these drugs primarily to help patients manage type 2 diabetes. Shortly after, medications like Ozempic, Wegovy, and Mounjaro made global headlines for their remarkable weight…
A new obesity drug is getting a lot of attention, and for good reason. In a large clinical trial, people who took mazdutide lost more than 16% of their body weight in about a year. That is a significant number,…
Fibromyalgia is a complex and often misunderstood health condition. For the estimated two to four percent of adults in the United States living with the disorder, daily life can be a profound struggle. Patients routinely face chronic, widespread muscle and…